Ultrase (Axcan Scandipharm)
Brand names,
Ultrase (Axcan Scandipharm)
Analogs
Ultrase (Axcan Scandipharm)
Brand Names Mixture
Ultrase (Axcan Scandipharm)
Chemical_Formula
C5850H8902N1606O1739S49
Ultrase (Axcan Scandipharm)
RX_link
http://www.rxlist.com/cgi/generic2/pancrel.htm
Ultrase (Axcan Scandipharm)
fda sheet
Ultrase (Axcan Scandipharm)
msds (material safety sheet)
Ultrase (Axcan Scandipharm)
Synthesis Reference
No information avaliable
Ultrase (Axcan Scandipharm)
Molecular Weight
131125.6
Ultrase (Axcan Scandipharm)
Melting Point
48-50 oC (Vinogradov, A.A. et al., Protein Eng. 14:683-689 (2001)).
Ultrase (Axcan Scandipharm)
H2O Solubility
No information avaliable
Ultrase (Axcan Scandipharm)
State
Liquid
Ultrase (Axcan Scandipharm)
LogP
No information avaliable
Ultrase (Axcan Scandipharm)
Dosage Forms
Tablet
Ultrase (Axcan Scandipharm)
Indication
For treatment of cystic fibrosis, chronic pancreatitis, pancreatic duct blockage
Ultrase (Axcan Scandipharm)
Pharmacology
Used in the treatment of cystic fibrosis or pancreatic dysfunction, pancrelipase helps improve fat digestion in the small intestine. Specifically, the lipase, protease and amylase components break down fat, protein, and starches, respectively, in the small intestine. Lipase hydrolyzes fats into glycerol and fatty acids. Protease converts proteins into proteoses and derived substances, while amylase converts starches into dextrins and sugars. Pancreatic enzymes are used to correct maldigestion, malabsorption and pain associated with pancreatic insufficiency. The major maldigestion/malabsorption problems arise from incomplete fat digestion. Exogenous pancrelipase reduces the amount of nitrogen and fat excreted in the stool.
Ultrase (Axcan Scandipharm)
Absorption
No information avaliable
Ultrase (Axcan Scandipharm)
side effects and Toxicity
No information avaliable
Ultrase (Axcan Scandipharm)
Patient Information
No information avaliable
Ultrase (Axcan Scandipharm)
Organisms Affected
Humans and other mammals